ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,741Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 393

$810K Total Retail Price of All Prescriptions

Rank: 12 out of 393

1,111 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,111 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

23% of this provider’s 1,111 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 15,689 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 1,114 1,015 1 2
LOVASTATIN 1,074 971 2 14
HYDROCODONE-ACETAMINOPHEN 970 745 S3 3 5
AMLODIPINE BESYLATE 828 733 4 4
SIMVASTATIN 784 662 5 1
LEVOTHYROXINE SODIUM 761 724 6 3
OMEPRAZOLE 632 501 7 6
METOPROLOL TARTRATE 452 405 8 9
METFORMIN HCL 443 362 9 7
ALENDRONATE SODIUM 405 387 10 16
ZOLPIDEM TARTRATE 377 326 11 11
LOSARTAN POTASSIUM 311 274 12 12
GABAPENTIN 281 195 13 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 257 213 14 24
WARFARIN SODIUM 243 223 15 17
FUROSEMIDE 231 184 16 8
ATENOLOL 210 171 17 13
GLIPIZIDE 204 167 18 32
FLUOXETINE HCL 197 166 19 37
HYDROCHLOROTHIAZIDE 192 161 20 10
GEMFIBROZIL 172 162 21 62
HYDRALAZINE HCL 167 160 22 64
AZITHROMYCIN 160 132 23 35
DONEPEZIL HCL 158 157 24 34
CITALOPRAM HBR 152 105 25 23
IBUPROFEN 145 110 26 55
TRICOR 135 95 27 128
ATORVASTATIN CALCIUM 128 86 28 19
TAMSULOSIN HCL 123 116 29 25
ACETAMINOPHEN-CODEINE 120 111 S3 30 145
NEXIUM 117 85 31 84
LOSARTAN-HYDROCHLOROTHIAZIDE 115 100 32 31
FELODIPINE ER 114 111 33 130
RANITIDINE HCL 108 90 34 29
GLYBURIDE 107 104 R 35 46
POTASSIUM CHLORIDE 99 96 36 20
CIPROFLOXACIN HCL 97 83 37 57
ALLOPURINOL 97 80 37 26
AMITRIPTYLINE HCL 94 47 R 39 72
CLOPIDOGREL 94 89 39 33
SERTRALINE HCL 92 77 41 28
OXYCODONE HCL 91 61 S2 42 36
PLAVIX 87 86 43 51
AMANTADINE 84 71 44 244
OXYBUTYNIN CHLORIDE 83 73 45 90
SPIRIVA 79 63 46 41
MECLIZINE HCL 79 58 46 163
OXYCODONE-ACETAMINOPHEN 78 55 S2 48 71
PRAVASTATIN SODIUM 77 73 49 18
PROAIR HFA 77 39 49 68
FENOFIBRATE 76 56 51 43
ADVAIR DISKUS 76 70 51 53
DIGOXIN 73 73 53 66
TERAZOSIN HCL 73 73 53 38
BACLOFEN 73 52 53 79
NAPROXEN 72 58 56 85
CLONIDINE 72 61 56 185
FLUTICASONE PROPIONATE 69 43 58 27
TRIAMTERENE-HCTZ 66 66 59 49
VENTOLIN HFA 65 51 60 42
PAROXETINE HCL 62 41 61 61
TRAMADOL HCL 62 43 61 30
LABETALOL HCL 61 46 63 143
METOPROLOL SUCCINATE 61 59 63 22
CLONIDINE HCL 59 53 65 50
CARISOPRODOL 59 23 R 65 45
DIOVAN 56 46 67 69
DILTIAZEM 24HR CD 56 52 67 152
PREDNISONE 55 44 69 65
TRAZODONE HCL 55 35 69 47
CRESTOR 55 55 69 52
ESTRADIOL 54 41 R 72 93
AVODART 54 54 72 189
NYSTATIN-TRIAMCINOLONE 54 41 72 231
ROPINIROLE HCL 54 54 72 121
NIFEDIPINE ER 53 45 76 91
ISOSORBIDE MONONITRATE ER 52 46 77 67
MELOXICAM 52 36 77 58
CYMBALTA 52 21 77 88
BUPROPION HCL 51 49 80 305
PROPRANOLOL HCL 51 51 80 134
OXYCODONE HCL-ACETAMINOPHEN 50 30 S2 82 54
METHOTREXATE 50 40 82 177
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.